Enzyme (and additives)a | Tm(app) (°C) | pH (buffer) | Method | Domains | Reversible/irreversible folding | References |
---|---|---|---|---|---|---|
mgLPMO10-holo | 83.0 | 6.0 (phosphate) | DSC | AA10-CBM2 | Irreversible | This study |
mgLPMO10-apo | 73.0 | 6.0 (phosphate) | DSC | AA10-CBM2 | Irreversible | This study |
mgLPMO10CD-holo | 76.0 | 6.0 (phosphate) | DSC | AA10 | Irreversible | This study |
ScLPMO10C-holo | 64.1 | 6.0 (phosphate) | DSF | AA10-CBM2 | ND | Jensen et al. [38] |
SmLPMO10A-holo | 71.2 | 6.0 (phosphate) | DSF | AA10 | ND | Jensen et al. [38] |
SmLPMO10A-holo | 74.4 | 5.0 (acetate) | DSC | AA10 | Reversible | Sugimoto et al. [45] |
SmLPMO10A-apo | 65.6 | 5.0 (acetate) | DSC | AA10 | Reversible | Sugimoto et al. [45] |
SmLPMO10A | 70.3 | 8.0 (Tris–HCl) | ITF | AA10 | ND | Vaaje-Kolstad et al. [46] |
EfLPMO10A | 72.0 | 8.0 (Tris–HCl) | ITF | AA10 | ND | Vaaje-Kolstad et al. [46] |
BaLPMO10A-holo | 65.0 | 5.0 (acetate) | DSF | AA10 | ND | Hemsworth et al. [47] |
BaLPMO10A-apo | 46.0 | 5.0 (acetate) | DSF | AA10 | ND | Hemsworth et al. [47] |
BaLPMO10A + EDTA | 48.0 | 5.0 (acetate) | DSF | AA10 | ND | Hemsworth et al. [47] |
BaLPMO10A-Zn2+ | 52.0 | 5.0 (acetate) | DSF | AA10 | ND | Hemsworth et al. [47] |
BaLPMO10A-Ni2+ | 53.0 | 5.0 (acetate) | DSF | AA10 | ND | Hemsworth et al. [47] |
BaLPMO10A-Mn2+ | 46.0 | 5.0 (acetate) | DSF | AA10 | ND | Hemsworth et al. [47] |
TaLPMO9A-holo | 74.3 | 7.0 (MOPS) | ITF | AA9 | Reversible | Singh et al. [48] |
TaLPMO9A-apo | 65.2 | 7.0 (MOPS) | ITF | AA9 | Reversible | Singh et al. [48] |
TaLPMO9A-holo (deglycosylated) | 67.9 | 7.0 (phosphate) | ITF | AA9 | Reversible | Singh et al. [48] |
MtLPMO9B | 75.0b | 7.0 (phosphate) | CD | AA9-CBM1 | Irreversible | Frommhagen et al. [49] |
MtLPMO9D | 68.0b | 7.0 (phosphate) | CD | AA9 | Irreversible | Frommhagen et al. [49] |
NcLPMO9C-holo | 61.5 | 6.0 (phosphate) | DSF | AA9-CBM1 | ND | Kracher et al. [44]c |
NcLPMO9C-holo | 44.0 | 4.0 (acetate) | DSF | AA9-CBM1 | ND | Kracher et al. [44] |
NcLPMO9C-holo | 34.7 | 4.0 (citrate) | DSF | AA9-CBM1 | ND | Kracher et al. [44] |
NcLPMO9C-apo (+ EDTA) | 52.7 | 6.0 (phosphate) | DSF | AA9-CBM1 | ND | Kracher et al. [44] |
NcLPMO9C-holo + AscA | 48.8 | 6.0 (phosphate) | DSF | AA9-CBM1 | ND | Kracher et al. [44] |
NcLPMO9C-holo + xyloglucan | 61.4 | 6.0 (phosphate) | DSF | AA9-CBM1 | ND | Kracher et al. [44] |
NcLPMO9C-holo + xyloglucan + AscA | 60.4 | 6.0 (phosphate) | DSF | AA9-CBM1 | ND | Kracher et al. [44] |
NcLPMO9C | 63.0 | 6.0 (phosphate) | DSC | AA9-CBM1 | ND | Kittl et al. [30] |
NcLPMO9J | 66.9 | 6.0 (phosphate) | DSC | AA9-CBM1 | ND | Kittl et al. [30] |
NcLPMO9F | 68.9 | 6.0 (phosphate) | DSC | AA9 | ND | Kittl et al. [30] |
NcLPMO9E | 67.9 | 6.0 (phosphate) | DSC | AA9-CBM1 | ND | Kittl et al. [30] |
PvLPMO9A-holo | 59.6 | 7.0 (Polybuffer 96, GE Healthcare) | DSC | AA9-C-termd | ND | Semenova et al. [50] |
PvLPMO9A-apo | 49.9 | 7.0 (Polybuffer 96, GE Healthcare) | DSC | AA9-C-termd | ND | Semenova et al. [50] |